A DNA Methylation Database of Human and Mouse Hematological Malignancy Cell Lines

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2024 Nov 23

PMID 39578534

Authors

Aleix Noguera-Castells

Carlos A Garcia-Prieto

Gerardo Ferrer

Veronica Davalos

Fernando Setien

Eulalia Genesca

Jordi Ribera

Josep M Ribera

Manel Esteller

Affiliations

Soon will be listed here.

References

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

Moran S, Arribas C, Esteller M . Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 2015; 8(3):389-99. PMC: 4864062. DOI: 10.2217/epi.15.114. View

. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nat Biotechnol. 2016; 34(7):726-37. DOI: 10.1038/nbt.3605. View

Bashi A, Coker E, Bulusu K, Jaaks P, Crafter C, Lightfoot H . Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations. Cancer Discov. 2024; 14(5):846-865. PMC: 11061612. DOI: 10.1158/2159-8290.CD-23-0388. View

Garcia-Prieto C, Alvarez-Errico D, Musulen E, Bueno-Costa A, Vazquez B, Vaquero A . Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome. Epigenetics. 2022; 17(12):1677-1685. PMC: 9621044. DOI: 10.1080/15592294.2022.2053816. View

Reinhold W, Varma S, Sunshine M, Rajapakse V, Luna A, Kohn K . The NCI-60 Methylome and Its Integration into CellMiner. Cancer Res. 2016; 77(3):601-612. PMC: 5290136. DOI: 10.1158/0008-5472.CAN-16-0655. View

Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana M, Bibikova M . Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011; 6(6):692-702. DOI: 10.4161/epi.6.6.16196. View

Iorio F, Knijnenburg T, Vis D, Bignell G, Menden M, Schubert M . A Landscape of Pharmacogenomic Interactions in Cancer. Cell. 2016; 166(3):740-754. PMC: 4967469. DOI: 10.1016/j.cell.2016.06.017. View

Ghandi M, Huang F, Jane-Valbuena J, Kryukov G, Lo C, McDonald 3rd E . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019; 569(7757):503-508. PMC: 6697103. DOI: 10.1038/s41586-019-1186-3. View

10.

Tsesmetzis N, Paulin C, Rudd S, Herold N . Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. Cancers (Basel). 2018; 10(7). PMC: 6071274. DOI: 10.3390/cancers10070240. View

11.

Davalos V, Esteller M . Cancer epigenetics in clinical practice. CA Cancer J Clin. 2022; 73(4):376-424. DOI: 10.3322/caac.21765. View

12.

SCHERER W, SYVERTON J, GEY G . Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953; 97(5):695-710. PMC: 2136303. DOI: 10.1084/jem.97.5.695. View